AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
YouTube Viewers YouTube Viewers
2.73M subscribers
5,455 views
0

 Published On Dec 7, 2023

CNBC's David Faber delivers his latest Faber Report.

show more

Share/Embed